ABLX
Ablynx NV

162
Loading...
Loading...
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.
Sector:
Health Technology
Industry:
Biotechnology
Employees:

Frequently Asked Questions

What is Market Cap of Ablynx nv Sponsored ADR?
What is the 52-week high for Ablynx nv Sponsored ADR?
What is the 52-week low for Ablynx nv Sponsored ADR?
What is Ablynx nv Sponsored ADR stock price today?
What was Ablynx nv Sponsored ADR stock price yesterday?
What is the PE ratio of Ablynx nv Sponsored ADR?
What is the Price-to-Book ratio of Ablynx nv Sponsored ADR?
What is Ablynx nv Sponsored ADR's EBITDA?
What is the 50-day moving average of Ablynx nv Sponsored ADR?
How many employess does Ablynx nv Sponsored ADR has?

Latest ABLX News

View
No ABLX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.